Get the Stockscreener App
2.11
0.94%
-0.0201
After Hours:
2.12
0.01
+0.47%
Ensysce Biosciences Inc stock is traded at $2.11, with a volume of 37,956.
It is down -0.94% in the last 24 hours and up +0.96% over the past month.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
See More
Previous Close:
$2.1301
Open:
$2.12
24h Volume:
37,956
Relative Volume:
0.12
Market Cap:
$6.26M
Revenue:
-
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.701
EPS:
-3.01
Net Cash Flow:
$-9.78M
1W Performance:
-1.17%
1M Performance:
+0.96%
6M Performance:
-53.73%
1Y Performance:
-55.34%
1-Day Range:
$2.07
$2.1337
1-Week Range:
$2.02
$2.19
52-Week Range:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Name
Ensysce Biosciences Inc
Sector
Industry
Phone
(858) 263-4196
Address
7946 IVANHOE AVENUE, LA JOLLA
Compare ENSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.11 | 6.35M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Stock (ENSC) Latest News
How to read the order book for Ensysce Biosciences Inc.Weekly Investment Report & Expert Curated Trade Ideas - Newser
Risk vs reward if holding onto Ensysce Biosciences Inc.Share Buyback & Capital Efficient Trading Techniques - Newser
What indicators show strength in Ensysce Biosciences Inc.Quarterly Market Review & Fast Gain Stock Trading Tips - Newser
Using fundamentals and technicals on Ensysce Biosciences Inc.Market Weekly Review & Weekly Momentum Picks - Newser
Can Ensysce Biosciences Inc. recover in the next quarterAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Tools to assess Ensysce Biosciences Inc.’s risk profileEarnings Summary Report & AI Driven Price Predictions - Newser
Live market analysis of Ensysce Biosciences Inc.July 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
How to use a screener to detect Ensysce Biosciences Inc. breakoutsPortfolio Return Summary & Precise Entry and Exit Recommendations - Newser
How institutional ownership impacts Ensysce Biosciences Inc. stockMarket Trend Review & Free Daily Entry Point Trade Alerts - Newser
Is Ensysce Biosciences Inc. stock bottoming outWeekly Investment Summary & Daily Volume Surge Trade Alerts - Newser
When is the best time to exit Ensysce Biosciences Inc.Market Volume Summary & Real-Time Buy Zone Alerts - Newser
Is Ensysce Biosciences Inc. stock poised for growthWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - Newser
Ensysce Biosciences Inc. stock chart pattern explainedJuly 2025 Earnings & Entry and Exit Point Strategies - Newser
Is Ensysce Biosciences Inc. stock ready for a breakoutMarket Performance Recap & Breakout Confirmation Alerts - Newser
How to track smart money flows in Ensysce Biosciences Inc.Product Launch & Reliable Entry Point Alerts - Newser
How to forecast Ensysce Biosciences Inc. trends using time series2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Forecasting Ensysce Biosciences Inc. price range with options dataJobs Report & Weekly Consistent Profit Watchlists - Newser
Pattern recognition hints at Ensysce Biosciences Inc. upsideGap Up & Verified Stock Trade Ideas - Newser
Can a trend reversal in Ensysce Biosciences Inc. lead to recoverySwing Trade & Weekly Hot Stock Watchlists - Newser
Using data tools to time your Ensysce Biosciences Inc. exit2025 Major Catalysts & High Accuracy Trade Alerts - Newser
Published on: 2025-09-11 07:04:58 - Newser
Can volume confirm reversal in Ensysce Biosciences Inc.2025 Dividend Review & Verified Entry Point Detection - Newser
Using RSI to spot recovery in Ensysce Biosciences Inc.July 2025 Intraday Action & Daily Oversold Bounce Ideas - Newser
What candlestick patterns are forming on Ensysce Biosciences Inc.2025 Sector Review & Precise Swing Trade Alerts - Newser
Short interest data insights for Ensysce Biosciences Inc.Quarterly Market Review & Precise Trade Entry Recommendations - Newser
Can Ensysce Biosciences Inc. rally from current levelsForecast Cut & Free Growth Oriented Trading Recommendations - Newser
Ensysce Biosciences Inc. stock momentum explained2025 Buyback Activity & Precise Buy Zone Tips - Newser
Ensysce Biosciences Inc Stock (ENSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):